Tool overview
Klaimee is listed under Finance AI tools.
What is Klaimee?
Klaimee evaluates, certifies, guarantees, and insures autonomous AI agents. It assesses agent risk across operational and adversarial dimensions, produces procurement-ready evidence, provides a certification badge and financial guarantee, and offers AI-specific liability coverage.
Best for
AI vendors and enterprises that need procurement-ready proof of agent risk controls and coverage
Who is it for?
Decision note
Suitable for evaluation after confirming final commercial terms, permissions, data handling, and edit-screen aliases. Keep Needs Review enabled until a human verifies the published profile.
Key features
Risk assessment across eight agent-failure dimensions
Procurement-ready certification report
Remediation recommendations and verified badge
Financial guarantee tied to certification
AI-specific third-party and first-party liability coverage
Adversarial testing playground for repeated evaluation
Use cases
Certifying an AI agent before enterprise deployment
Proving coverage during procurement review
Insuring wrongful agent actions or outputs
Testing agents against adversarial scenarios
Assessing internal agents with write access
Pros
- Combines technical evaluation with financial risk transfer
- Covers both third-party and first-party losses
- Designed specifically for autonomous-agent exposure
- Produces documentation useful for enterprise procurement
Cons
- Eligibility and premiums depend on underwriting
- Coverage is limited to bounded non-safety-critical use cases
- Certification does not eliminate operational risk
Limitations
Insurance terms, exclusions, limits, jurisdictions, and certification outcomes vary by applicant. Companies must review policy wording with qualified insurance and legal professionals and should not treat certification as proof that an agent is error-free.
Pricing details
Billing options
Pricing note
Certification, guarantee, and insurance terms depend on the agent, risk score, requested coverage, and underwriting. A temporary public adversarial-testing window was offered, but no standard public recurring price or ongoing free commercial plan was published.
Supported languages
- English




Please log in to join the discussion.